Cargando…
Systematic in silico analysis of clinically tested drugs for reducing amyloid‐beta plaque accumulation in Alzheimer's disease
INTRODUCTION: Despite strong evidence linking amyloid beta (Aβ) to Alzheimer's disease, most clinical trials have shown no clinical efficacy for reasons that remain unclear. To understand why, we developed a quantitative systems pharmacology (QSP) model for seven therapeutics: aducanumab, crene...
Autores principales: | Madrasi, Kumpal, Das, Raibatak, Mohmmadabdul, Hafiz, Lin, Lin, Hyman, Bradley T., Lauffenburger, Douglas A., Albers, Mark W., Rissman, Robert A., Burke, John M., Apgar, Joshua F., Wille, Lucia, Gruenbaum, Lore, Hua, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478725/ https://www.ncbi.nlm.nih.gov/pubmed/33938131 http://dx.doi.org/10.1002/alz.12312 |
Ejemplares similares
-
Quantitative systems pharmacology model of GITR‐mediated T cell dynamics in tumor microenvironment
por: Ji, Yan, et al.
Publicado: (2023) -
Mathematical modeling of SARS-CoV-2 viral dynamics and treatment with monoclonal antibodies
por: Kareva, Irina, et al.
Publicado: (2022) -
Investigation of the Dermal Absorption and Irritation Potential of Sertaconazole Nitrate Anhydrous Gel
por: Manian, Mahima, et al.
Publicado: (2016) -
Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET
por: Therriault, Joseph, et al.
Publicado: (2023) -
Intranasal neprilysin rapidly eliminates amyloid-beta plaques, but causes plaque compensations: the explanation why the amyloid-beta cascade may fail?
por: Humpel, Christian
Publicado: (2022)